Clincosm LogoSign in Get a demo

COVID-19 Phobia in Patients With Bronchiectasis During Covid-19 Pandemic

Sponsor
Hacettepe University (Other)
Overall Status
Completed
CT.gov ID
NCT04487873
Collaborator
(none)
74
Enrollment
1
Location
6.3
Actual Duration (Months)
11.7
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

In the literature, there are no studies evaluating COVID-19 phobia, quality of life, health anxiety, physical activity level and quality of sleep in patients with bronchiectasis during COVID-19 pandemic. The investigators will evaluate these parameters in patients with bronchiectasis and compare the findings of healthy individuals during COVID-19 pandemic

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    74 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Prospective
    Official Title:
    COVID-19 Phobia and Quality of Life in Patients With Bronchiectasis During Covid-19 Pandemic
    Actual Study Start Date :
    Jul 23, 2020
    Actual Primary Completion Date :
    Dec 18, 2020
    Actual Study Completion Date :
    Jan 31, 2021

    Arms and Interventions

    Arm Intervention/Treatment
    Bronchiectasis

    Having been diagnosed with non-cystic fibrosis bronchiectasis
    Healthy individuals

    Healthy individuals without chronic disease

    Outcome Measures

    Primary Outcome Measures

    1. COVID-19 Phobia [5 minutes]

      COVID-19 phobia was evaluated with COVID-19 Phobia Scale (C19P-S) and total score ranges from 20-100. Lower scores mean better outcome.

    2. Qol [10 minutes]

      Quality of life was evaluated with Nottingham Health Profile

    Secondary Outcome Measures

    1. Health anxiety [10 minutes]

      Health anxiety was evaluated with Health Anxiety Inventory

    2. Physical activity [5 minutes]

      Physical activity level was evaluated with International Physical Activity Questionnaire - Short Form (IPAQ-SF)

    3. Quality of sleep [10 minutes]

      Quality of sleep was evaluated with Pittsburgh Sleep Quality Index

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 60 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:

    • Having been diagnosed with non-cystic fibrosis bronchiectasis

    • No acute bronchiectasis exacerbation or infection in the past 2 weeks

    • Volunteering to participate in the research

    Exclusion Criteria:

    • Having a cognitive problem

    • Not being literate

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Hacettepe University, Faculty of Physical Therapy and Rehabilitation Ankara Turkey

    Sponsors and Collaborators

    • Hacettepe University

    Investigators

    • Principal Investigator: Merve Firat, MSc, Hacettepe University
    • Study Director: Naciye Vardar-Yagli, PhD, Hacettepe University
    • Study Chair: Deniz İnal-İnce, Professor, Hacettepe University
    • Study Chair: Melda Saglam, PhD, Hacettepe University
    • Study Chair: Ebru Calik-Kütükcü, PhD, Hacettepe University
    • Study Chair: Aslıhan Cakmak, MSc, Hacettepe University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Merve Firat, Principal Investigator, Hacettepe University
    ClinicalTrials.gov Identifier:
    NCT04487873
    Other Study ID Numbers:
    • GO 20/602
    First Posted:
    Jul 27, 2020
    Last Update Posted:
    May 13, 2021
    Last Verified:
    Dec 1, 2020
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Merve Firat, Principal Investigator, Hacettepe University
    phobia
    quality of life
    health anxiety
    Additional relevant MeSH terms:
    COVID-19
    Bronchiectasis

    Study Results

    No Results Posted as of May 13, 2021